EnWave CorporationA 2013 TSX Venture 50 Company

Radiant Energy Vacuum Dehydration Technology

EnWave Corporation offers industrial-scale dehydration technology for commercial applications in the food and pharmaceutical spaces. EnWave's proprietary Radiant Energy Vacuum ("REV™") platforms offer flexible, efficient processing. EnWave's mission is to establish its REV™ technology as the new global dehydration standard: faster and cheaper than freeze drying, with better quality than air drying or spray drying.

  • nutraREV
    Food Industry Applications

    Designed for the dehydration of fruits, vegetables, herbs, dairy products, meats and seafood, nutraREV® processed products have higher nutritional content and improved appearance, flavour and texture over conventional methods. Commercial-scale nutraREV™ machinery can be built up to 150kW in power and is currently available.

    Read More

  • quantaREV
    Food Industry Applications

    Designed for high-volume, low-temperature dehydration of solids, liquids, granular or encapsulated products. quantaREV™ is currently being tested on a pilot basis by EnWave's collaboration partners on a variety of food and other products. Availability of commercial quantaREV™ machinery is expected in early 2015.

    Read More

  • powderREV
    Pharmaceutical Applications

    Designed for bulk dehydration of temperature-sensitive biomaterials such as bacteria and enzymes. EnWave Corporation has developed powderREV™ as a high-speed, lower-energy, continuous alternative to freeze drying. Commercial units are currently available.

    Read More

  • freezeREV
    Pharmaceutical Applications

    Designed for the dehydration of temperature sensitive biomaterials in vials. freezeREV™ is a multi-vial prototype technology that acts as an accelerated freeze dryer to produce room temperature stable biopharmaceuticals and reagents.

    Read More

  • bioREV
    Pharmaceutical Applications

    Designed for the dehydration of temperature sensitive biomaterials in vials. Single-vial prototype bioREV™ is being tested as a method to produce room temperature stable vaccines and antibodies for worldwide shipment requiring less refrigeration.

    Read More